JEL
Live / Applied — Second extension granted (statement of use) (as of 05 Jun 2025)
What this means for you
Not registered yet, but its 02 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97576363
- Mark type
- Word mark
- Filed
- 02 Sept 2022
- Published for opposition
- 23 Apr 2024
- Attorney of record
- Joe McKinney Muncy
Goods and services
- Class 005 — Pharmaceuticals: Glaucoma agents; Irrigating solutions for eye use; Medicated eye washes; Eye drops; Ocular pharmaceuticals; Ophthalmic preparations; Ophthalmologic preparations; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products for ophthalmological use; Dermatological pharmaceutical products; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicated dermatological preparations and substances; Medicated skin preparation for use in treating wound healing; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Medicated ointments for treating dermatological conditions; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated skin care preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations for skin care; Medicinal creams for skin care; Frostbite salve for pharmaceutical purposes; Poultices; Gelatine for medical purposes; wound-healing ointments for pharmaceutical purposes; Sunburn ointments; Acne treatment preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of gel that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for prostatic diseases and conditions; Pharmaceutical preparations for benign prostatic hyperplasia; Pharmaceutical preparations for the treatment and prevention of prostatic diseases and conditions; Pharmaceutical preparations for the treatment and prevention of benign prostatic hyperplasia
Owner
- AiViva Biopharma, Inc., Dover, Kent County,, DE, US
- AiViva Biopharma, Inc., Dover, Kent County,, DE, US
Prosecution history
- 08 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Jun 2025 — SOU EXTENSION 2 GRANTED
- 05 Jun 2025 — SOU EXTENSION 2 FILED
- 05 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jun 2024 — SOU EXTENSION 1 GRANTED
- 28 Jun 2024 — SOU EXTENSION 1 FILED
- 28 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Apr 2024 — PUBLISHED FOR OPPOSITION
- 03 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Mar 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED